Farther Finance Advisors’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6K | Buy |
4,871
+1,629
| +50% | +$5.54K | ﹤0.01% | 2786 |
|
|
2025
Q1 | $12.7K | Buy |
3,242
+2,407
| +288% | +$9.44K | ﹤0.01% | 2616 |
|
|
2024
Q4 | $5.42K | Sell |
835
-30
| -3% | -$195 | ﹤0.01% | 2633 |
|
|
2024
Q3 | $4.79K | Buy |
865
+17
| +2% | +$94 | ﹤0.01% | 2658 |
|
|
2024
Q2 | $4.76K | Buy |
848
+41
| +5% | +$230 | ﹤0.01% | 2418 |
|
|
2024
Q1 | $5.41K | Hold |
807
| – | – | ﹤0.01% | 2035 |
|
|
2023
Q4 | $7.36K | Buy |
+807
| New | +$7.36K | ﹤0.01% | 1763 |
|